Elucidating the exact pharmacological system of motion (MOA) of naturally transpiring compounds is often demanding. Whilst Tarselli et al. (60) developed the very first de novo artificial pathway to conolidine and showcased that this naturally transpiring compound proficiently suppresses responses to the two chemically induced and inflammation-deri… Read More